Drug intelligence / Profile preview

Fluorouridine (Non-specific)

Development stage
Unknown
Lead developer
Roche
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral, Intra-arterial, Intravenous
01

Overview

"Fluorouridine" is a non-specific term that can refer to at least two distinct nucleoside analogs: 5-Fluorouridine and 4'-Fluorouridine. 5-Fluorouridine (FUrd) is a pyrimidine nucleoside analog that has been investigated for its anticancer properties. It acts by targeting uridine phosphorylase and is also a metabolite of 5-fluorouracil. Its mechanism of action involves interfering with DNA and RNA synthesis, primarily by inhibiting thymidylate synthase and being incorporated into RNA, leading to cell death in rapidly dividing cancer cells. 4'-Fluorouridine (4'-FlU, EIDD-2749) is a ribonucleoside analog developed as an oral antiviral agent. It demonstrates efficacy against a broad spectrum of RNA viruses, including SARS-CoV-2, Respiratory Syncytial Virus (RSV), avian influenza, and various hemorrhagic fever viruses (such as Nipah, Crimean-Congo, orthohantaviruses, and arenaviruses). Its antiviral mechanism involves inhibiting RNA-dependent RNA polymerase (RdRp), leading to transcriptional stalling and preventing viral replication.

Other names
5-Fluorouracil 1-beta-D-ribofuranoside5-Fur5-Fluoro-uridine
02

Targets

TS (Thymidylate synthase)Shiga toxinRdRp (Coronavirus RNA-dependent RNA polymerase)UPP1 (Uridine phosphorylase)DPYD (Dihydropyrimidine dehydrogenase)

Beyond the preview

Go deeper on Fluorouridine (Non-specific).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fluorouridine (Non-specific).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call